You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VTE recurrence rate

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Detroit, Michigan
    Henry Ford Health System
Jul 18, 2022

Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Lexington, Kentucky
  • +2 more
Jun 6, 2022

Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism Trial in Netherlands (Randomised treatment advice (discontinue vs

Recruiting
  • Venous Thromboembolism
  • +3 more
  • Randomised treatment advice (discontinue vs continue after 3 months)
  • +4 more
  • Leiden, South-Holland, Netherlands
  • +16 more
Oct 17, 2023

Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate

Not yet recruiting
  • Cancer of Cervix
  • Apoptosis
  • Immunohistochemistry
  • (no location specified)
Nov 17, 2023

Wire in Shouldice Surgery to Keep Recurrence Rate Low After One

Recruiting
  • Inguinal Hernia
  • suture material
  • Thornhill, Ontario, Canada
    Shouldice Hospital
May 18, 2023

Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia

Enrolling by invitation
  • Hiatal Hernia Large
  • repair of giant hiatal hernia with mesh and anterior fundoplication
  • (no location specified)
Oct 25, 2022

Acute Ischemic Stroke, Stroke Recrudescence, Quality Improvement Trial in Hangzhou (multilevel system intervention based on

Not yet recruiting
  • Acute Ischemic Stroke
  • +2 more
  • multilevel system intervention based on information platform
  • Hangzhou, Zhejiang, China
    Min Lou
May 2, 2023

Recurrence Rate of Hemorrhoidal Disease at 10 Years and More

Recruiting
  • Hemorrhoidal Disease
  • HAL (Hemorrhoidal Artery Ligation) - RAR (Recto-Anal Repair)
  • Grenoble, France
    CHU Grenoble-alpes
Jan 10, 2023

Helicobacter Pylori Infection Trial in Medan (Esomeprazole, Lansoprazole, Amoxicillin)

Completed
  • Helicobacter Pylori Infection
  • Medan, North Sumatera, Indonesia
  • +1 more
May 16, 2023

Upper Urinary Tract Carcinoma Trial

Not yet recruiting
  • Upper Urinary Tract Carcinoma
    • (no location specified)
    Feb 7, 2023

    United Sates That Looks at Safety and Effectiveness of Pradaxa

    Not yet recruiting
    • Venous Thromboembolism
      • (no location specified)
      Aug 1, 2023

      Dupuytren's Disease Trial in Mulhouse, Pessac (Aponeurectomy with grafting, Aponeurectomy alone)

      Recruiting
      • Dupuytren's Disease
      • Aponeurectomy with grafting
      • Aponeurectomy alone
      • Mulhouse, France
      • +1 more
      Aug 4, 2022

      Descriptive Study of a Cohort of Orbital Solitary Fibrous Tumors

      Not yet recruiting
      • Orbital Tumor
      • Phone call
      • Paris, France
        Hôpital Fondation A. de Rothschild
      Nov 14, 2022

      Psychotic Episode Trial in France (Case management)

      Recruiting
      • Psychotic Episode
      • Case management
      • Clermont-Ferrand, France
      • +6 more
      Jan 2, 2023

      Prostate Cancer, HDR Trial in Rochester (High-Dose-Rate Brachytherapy)

      Recruiting
      • Prostate Cancer
      • HDR
      • High-Dose-Rate Brachytherapy
      • Rochester, New York
        University of Rochester
      Oct 29, 2021

      Recurrence of Dyschezia in Rectal Prolapse, Rectocele and

      Recruiting
      • Rectal Prolapse
      • Rectal prolapse, rectocele and elytrocele
      • Grenoble, France
        Chu Grenoble Alpes
      Jul 26, 2022

      Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)

      Not yet recruiting
      • Prostate Cancer
      • +5 more
      • Radiopharmaceutical 18F-JK-PSMA-7
      • Radiopharmaceutical 18F-Fluorocholine
      • (no location specified)
      Nov 17, 2022

      Recurrence of Trigeminal Neuralgia in Patient's Undergoing

      Completed
      • Trigeminal Neuralgia, Idiopathic
        • (no location specified)
        Oct 28, 2021

        Hemophilia A, Immune Tolerance Trial in Los Angeles (FVIII, Emicizumab)

        Active, not recruiting
        • Hemophilia A
        • Immune Tolerance
        • Los Angeles, California
          Childrens Hospital Los Angeles
        Mar 7, 2022

        Giant Cell Tumor of Bone Trial in Canada, United States (Zoledronic Acid)

        Recruiting
        • Giant Cell Tumor of Bone
        • Zoledronic Acid
        • Los Angeles, California
        • +15 more
        Oct 19, 2022

        Asthma Trial in Paris (2: Intervention, 1: Control)

        Completed
        • Asthma
        • 2: Intervention
        • 1: Control
        • Paris, France
          Service des Urgences, Hôpital Lariboisière
        Mar 9, 2022

        Rate of Perioperiative VTE in Colorectal Cancer Patients

        Unknown status
        • Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
          • (no location specified)
          Oct 9, 2020

          Renal Colic, Ureter Stone Trial (Tamsulosin Hcl 0.4Mg Cap, fexofenadine 180 mg Oral tablet)

          Not yet recruiting
          • Renal Colic
          • Ureter Stone
          • Tamsulosin Hcl 0.4Mg Cap
          • fexofenadine 180 mg Oral tablet
          • (no location specified)
          Dec 8, 2021

          Biochemical Relapse Fo Malignant Tumor of Prostate Trial in Taipei (18F-FACBC PET/CT)

          Recruiting
          • Biochemical Relapse Fo Malignant Neoplasm of Prostate
          • 18F-FACBC PET/CT
          • Taipei, Taiwan
            National Taiwan University Hospital
          Sep 8, 2021

          Fistula in Ano Trial in Najaf (Usinf thick loose sutures in seton techingues)

          Completed
          • Fistula in Ano
          • Usinf thick loose sutures in seton techingues
          • Najaf, An Najaf, Iraq
            Samer Al-Hakkak
          Jan 25, 2022